Post Categories
Vivani Shifts to Weight Management with an Exenatide Implant
April 1, 2024
As GLP-1 receptor agonist injections continue to gain acceptance as effective solutions for weight management and cardiovascular health, a tiny drug-delivering implant from Vivani…
EU Clinical Trial Regulation 536/2014 and CTIS: Common Questions and Answers
March 20, 2024
As reported in our previous CTIS-related blog post, the way clinical trials are documented in the European Union (EU) is changing. By January 31,…
Customized Therapies Offer Hope for Patients with Ultra-Rare Genetic Diseases
March 18, 2024
Leveraging rapid developments in gene therapy, researchers are designing new ways to target ultra-rare genetic diseases with treatments tailored to a patient’s specific genetic…
Navigating Changes to EU Clinical Trial Management: What You Need to Know
March 13, 2024
The face of clinical trials in the European Union (EU) is changing. By January 31, 2025, all ongoing clinical trials must move to the…
Psychoactive Drug Ibogaine Has Transformative Effects for Veterans with Traumatic Brain Injury
March 11, 2024
Traumatic brain injuries (TBIs), commonly experienced by military personnel, often incur deep damage and invisible scars. Such injuries are significant contributors to post-traumatic stress…
The Link Between Obesity Drugs and Brain Health
March 6, 2024
Glucagon-like peptide-1 (GLP-1) receptor agonists are arguably the hottest topic in medical innovation. The drugs semaglutide and tirzepatide, known under brand names like Ozempic,…
Advances in Treating Autoimmune Diseases Focus on Restoring Immune Tolerance
March 4, 2024
For decades, the battle against autoimmune diseases like type 1 diabetes, lupus, and multiple sclerosis has been an uphill struggle. Conventional treatments most often…
Research Challenges Conventional Wisdom on Obesity and Mortality
February 26, 2024
Research using data from a large U.S. health survey has disrupted conventional thinking about body mass index (BMI) and its role in predicting all-cause…
Fighting Disease Transmission From Humans to Chimpanzees: A Critical Conservation Effort
February 19, 2024
When a human virus was identified as the source of a 2017 respiratory disease outbreak among chimps at Uganda’s Kibale National Park, the discovery…
Could Newly Identified Genetic Variant Hold the Key to Metabolic Health?
February 14, 2024
Lurking among the vast genetic holdings of the UK Biobank data, researchers uncovered a potential gem — a gene variant linked to cardiometabolic health….
“It’s Incredible” — Breakthrough Spinal Implant Restores Walking Ability Lost Due to Parkinson’s Disease
February 12, 2024
Marc, a 63-year-old from Bordeaux, France, has lived with Parkinson’s disease for more than two decades. The disease had increasingly hindered his mobility, causing…
“Like Day and Night” — CRISPR’s Life-Changing Potential in Sickle Cell Disease
February 5, 2024
A groundbreaking gene editing therapy for sickle cell disease from CRISPR Therapeutics and Vertex Pharmaceuticals has received approval from the U.S. Food and Drug…
Encouraging Preclinical Results Show Gene Therapy Reduces Seizures
January 13, 2025
California-based Capsida Biotherapeutics has reported promising preclinical results for CAP-002, its gene therapy for developmental and epileptic encephalopathy (DEE) caused by mutations in the…
The Role of Fungi in Absorbing and Transferring Carbon
December 16, 2024
Travel to southwest London, and you’ll have the opportunity to visit Kew Gardens, a stunning botanical collection founded in 1840. The complex includes a…
Why Do Dogs Wag Their Tails So Much?
December 4, 2024
Dogs have been man’s best friend since they were first domesticated thousands of years ago. A friendly bark, a comforting nuzzle — dogs find…
New Antibiotic Could Simplify Gonorrhea Treatment
November 20, 2024
Gonorrhea is one of the most widespread sexually transmitted infections, with as many as 82 million new infections occurring worldwide each year. While not…
Promising Clinical Trial Results Suggest a Path Forward in Treating DMD
November 18, 2024
Duchenne muscular dystrophy (DMD) devastates young lives. This progressive disease, stemming from mutations in the gene that encodes the protein dystrophin, weakens muscles and…
Early Alzheimer’s Patients Benefit from Leqembi
November 13, 2024
Like many neurodegenerative diseases, early diagnosis and treatment of Alzheimer’s disease (AD) can greatly improve quality of life for individuals with the disease. Now,…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
